US Patent Issued to Roche Molecular Systems on Oct. 27 for "Compositions and methods for detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants having spike protein mutations" (California Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,489, issued on Oct. 27, was assigned to Roche Molecular Systems Inc. (Pleasanton, Calif.).

"Compositions and methods for detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants having spike protein mutations" was invented by Chitra Manohar (San Ramon, Calif.), Marcel R. Fontecha (San Ramon, Calif.), Christopher David Santini (Pleasant Hill, Calif.), Eugene Spier (Los Altos, Calif.), Jingtao Sun (San Ramon, Calif.), Michelle Elizabeth Yee (San Jose, Calif.) and Kalyani Mangipudi (Pleasanton, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods for the rapid detection of the presence of variants of Severe Acute Respira...